Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient

Bizunesh Dires Fenta,1 Alazar Berhe Aregawi,2 Teketel Tadesse Geremew,1 Berhanu Kelemework Fenta3 1Department of Pathology, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia; 2Department of Surgery, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama...

Full description

Bibliographic Details
Main Authors: Fenta BD, Aregawi AB, Geremew TT, Fenta BK
Format: Article
Language:English
Published: Dove Medical Press 2024-04-01
Series:International Medical Case Reports Journal
Subjects:
Online Access:https://www.dovepress.com/kaposis-sarcoma-with-primary-lymph-node-involvement-in-a-retroviral-in-peer-reviewed-fulltext-article-IMCRJ
_version_ 1827289044283817984
author Fenta BD
Aregawi AB
Geremew TT
Fenta BK
author_facet Fenta BD
Aregawi AB
Geremew TT
Fenta BK
author_sort Fenta BD
collection DOAJ
description Bizunesh Dires Fenta,1 Alazar Berhe Aregawi,2 Teketel Tadesse Geremew,1 Berhanu Kelemework Fenta3 1Department of Pathology, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia; 2Department of Surgery, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia; 3Department of Internal Medicine, Yanet Internal Medicine Specialized Center, Hawassa, Sidama, EthiopiaCorrespondence: Alazar Berhe Aregawi, Tel +251911914624, Email alazarberhe@hu.edu.etAbstract: One kind of angioproliferative disorder is Kaposi’s sarcoma (KS). Growth of spindle-shaped cells, edema, inflammation, and neoangiogenesis are its defining features. Because it lacks the typical indicators of malignancy, it is classified as an intermediate neoplasm. People who are immunocompromised, receiving organ transplants, or receiving antiretroviral therapy are linked to KS. Although lymph node involvement by KS is extremely uncommon, when it does occur, it usually manifests as either the epidemic form in (Human Immuno-deficiency) HIV-positive patients or the endemic form in Africans. There are four primary clinical manifestations of KS that have been documented: endemic, epidemic, iatrogenic, and classic. The diagnosis of KS is made by history, physical examination, and tissue biopsy. When treating localized disease, highly active antiretroviral therapy (HAART) may be sufficient to either improve or completely eradicate the illness. Nonetheless, chemotherapy and HAART would be necessary in the case of widespread illness. Here, we present the case of a 28-year-old female patient who is HIV positive and has a viral load that is not detected. She presented with generalized lymphadenopathy of 8 months duration. She had no cutaneous manifestations. The lymphadenopathy involved the tonsils, axilla, inguinal, and an unusual site, intraparotid on both sides. After a pathologic examination of the lymph nodes, she was found to have epidemic-type KS and was treated with HAART and chemotherapy. In our nation, we are not aware of any published case reports pertaining to a case like this. The purpose of this case report is to raise physicians’ awareness of this uncommon ailment and to encourage them to suspect KS when HIV patients exhibit generalized lymphadenopathy. The early initiation of systemic treatment is lifesaving for these patients.Keywords: Kaposi’s sarcoma, KS, Human immune-deficiency Virus, HIV, human herpes virus-8, Acquired Immuno-deficiency Syndrome, AIDS, generalized lymphadenopathy
first_indexed 2024-04-24T11:42:59Z
format Article
id doaj.art-aaea410b9e85472a9f1d1b86b5b4ed50
institution Directory Open Access Journal
issn 1179-142X
language English
last_indexed 2024-04-24T11:42:59Z
publishDate 2024-04-01
publisher Dove Medical Press
record_format Article
series International Medical Case Reports Journal
spelling doaj.art-aaea410b9e85472a9f1d1b86b5b4ed502024-04-09T17:51:08ZengDove Medical PressInternational Medical Case Reports Journal1179-142X2024-04-01Volume 1731131991800Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) PatientFenta BDAregawi ABGeremew TTFenta BKBizunesh Dires Fenta,1 Alazar Berhe Aregawi,2 Teketel Tadesse Geremew,1 Berhanu Kelemework Fenta3 1Department of Pathology, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia; 2Department of Surgery, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia; 3Department of Internal Medicine, Yanet Internal Medicine Specialized Center, Hawassa, Sidama, EthiopiaCorrespondence: Alazar Berhe Aregawi, Tel +251911914624, Email alazarberhe@hu.edu.etAbstract: One kind of angioproliferative disorder is Kaposi’s sarcoma (KS). Growth of spindle-shaped cells, edema, inflammation, and neoangiogenesis are its defining features. Because it lacks the typical indicators of malignancy, it is classified as an intermediate neoplasm. People who are immunocompromised, receiving organ transplants, or receiving antiretroviral therapy are linked to KS. Although lymph node involvement by KS is extremely uncommon, when it does occur, it usually manifests as either the epidemic form in (Human Immuno-deficiency) HIV-positive patients or the endemic form in Africans. There are four primary clinical manifestations of KS that have been documented: endemic, epidemic, iatrogenic, and classic. The diagnosis of KS is made by history, physical examination, and tissue biopsy. When treating localized disease, highly active antiretroviral therapy (HAART) may be sufficient to either improve or completely eradicate the illness. Nonetheless, chemotherapy and HAART would be necessary in the case of widespread illness. Here, we present the case of a 28-year-old female patient who is HIV positive and has a viral load that is not detected. She presented with generalized lymphadenopathy of 8 months duration. She had no cutaneous manifestations. The lymphadenopathy involved the tonsils, axilla, inguinal, and an unusual site, intraparotid on both sides. After a pathologic examination of the lymph nodes, she was found to have epidemic-type KS and was treated with HAART and chemotherapy. In our nation, we are not aware of any published case reports pertaining to a case like this. The purpose of this case report is to raise physicians’ awareness of this uncommon ailment and to encourage them to suspect KS when HIV patients exhibit generalized lymphadenopathy. The early initiation of systemic treatment is lifesaving for these patients.Keywords: Kaposi’s sarcoma, KS, Human immune-deficiency Virus, HIV, human herpes virus-8, Acquired Immuno-deficiency Syndrome, AIDS, generalized lymphadenopathyhttps://www.dovepress.com/kaposis-sarcoma-with-primary-lymph-node-involvement-in-a-retroviral-in-peer-reviewed-fulltext-article-IMCRJkaposi’s sarcomakshuman immune-deficiency virushivhuman herpes virus-8acquired immuno-deficiency syndromeaidsgeneralized lymphadenopathy
spellingShingle Fenta BD
Aregawi AB
Geremew TT
Fenta BK
Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient
International Medical Case Reports Journal
kaposi’s sarcoma
ks
human immune-deficiency virus
hiv
human herpes virus-8
acquired immuno-deficiency syndrome
aids
generalized lymphadenopathy
title Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient
title_full Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient
title_fullStr Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient
title_full_unstemmed Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient
title_short Kaposi’s Sarcoma with Primary Lymph Node Involvement in a Retroviral Infected (RVI) Patient
title_sort kaposi rsquo s sarcoma with primary lymph node involvement in a retroviral infected rvi patient
topic kaposi’s sarcoma
ks
human immune-deficiency virus
hiv
human herpes virus-8
acquired immuno-deficiency syndrome
aids
generalized lymphadenopathy
url https://www.dovepress.com/kaposis-sarcoma-with-primary-lymph-node-involvement-in-a-retroviral-in-peer-reviewed-fulltext-article-IMCRJ
work_keys_str_mv AT fentabd kaposirsquossarcomawithprimarylymphnodeinvolvementinaretroviralinfectedrvipatient
AT aregawiab kaposirsquossarcomawithprimarylymphnodeinvolvementinaretroviralinfectedrvipatient
AT geremewtt kaposirsquossarcomawithprimarylymphnodeinvolvementinaretroviralinfectedrvipatient
AT fentabk kaposirsquossarcomawithprimarylymphnodeinvolvementinaretroviralinfectedrvipatient